Picture of Celularity logo

CELU — Celularity News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Celularity Inc expected to post a loss of 34 cents a share - Earnings Preview

* Celularity Inc  CELU.OQ   CELU.O  is expected to report
results on November 15 (estimated).
* The New York City, New York-based company is expected to
report revenue of $1.73 million, according to the mean estimate
from 2 analysts, based on Refinitiv data.  
​* Refinitiv's mean analyst estimate for Celularity Inc is for a
loss of 34 cents per share. 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Celularity Inc
is $13​, about 44.3% above​ its last closing price of $7.24. ​​​
This summary was machine generated November 12 at 12:41 GMT. 
All figures in US dollars  unless otherwise stated

Recent news on Celularity

See all news